摘要 |
The described invention provides histone deacetylase (HDAC) inhibitor compounds with substituted benzimidazole, benzimidazolone and benzotriazole heterocycles showing selective inhibition of histone deacetylase isoform HDAC6. The described invention further provides methods of making such compounds and methods of inhibiting HDAC, treating HDAC- associated diseases, including cell proliferative disorders, such as cancer, autoimmune or inflammatory diseases and neurodegenerative diseases. |
申请人 |
THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY;DANA-FARBER CANCER INSTITUTE, INC.;ABEYWICKRAMA, CHANDIMA;BRADNER, JAMES, E.;PONNALA, SHASHIKANTH |
发明人 |
ABEYWICKRAMA, CHANDIMA;BRADNER, JAMES, E.;PONNALA, SHASHIKANTH |